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The intravenous injection of viruses within the influenza group is followed 
by a  characteristic fever in the rabbit and by the appearance of a  circulating 
pyrogen  (1).  This  material is  clearly separable from  the  injected virus and 
appears to be of endogenous origin. Since a close correlation exists between the 
duration of the febrile response and the presence of the pyrogen in the circula- 
tion, the release of endogenous pyrogen has been inferred to be an essential 
step in the pathogenesis of viral fever. 
The present paper deals with a  comparison of the action of the endogenous 
pyrogen in normal and in virus-tolerant animals. 
Methods 
G~era/.--The  Hickman strain of Newcastle disease virus (NDV) was employed exclusively. 
Techniques used for its growth and titration have been previously described (1). All methods 
pertaining to the selection of rabbits,  recording of temperatures,  and assay of circulating 
pyrogen are identical with those outlined in the preceding paper (1). 
Rabbits designated as "virus-tolerant" received a single injection of 4 ml. NDV on the 
day prior to the experiment. By this means they were rendered refractory to the pyrogenic 
effect of reinjected virus (2). 
Antibody Titration-Hemagglutination Inhibition (HI) Test.--The level of serum antibody 
was measured by inhibition  of viral hemaggintination (HI). Serum was diluted to 1:10  and 
heated at 56°C. for 30 minutes to inactivate naturally occurring inhibitors (3). Serial twofold 
dilutions of serum were then made in physiological saline. Virus was diluted to 16 HA units. 
0.2 ml. of virus was added to each tube containing 0.2 ml. diluted serum. 0.4 ml. of a 0.5 per 
cent suspension of washed chicken erythrocytes was then added. The tests were read at 45 
minutes at 4°C. 
Hyperimmune Scrum.--Immune serum was obtained from 3 rabbits. Each donor was given 
an initial inoculation of 10 ml. NDV intravenously. One week later, the first of a course of 4 
weekly intraperitoneal  injections was administered with the same dose of virus. Two weeks 
after the last injection, or 6 weeks after the onset of immunization, the donors were bled. The 
HI titers of the individual sera before pooling were: 1:1280, 1  : 5120, and 1:1280. 
* Supported by a grant from the United States Public Health Service (E-1564). 
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RESULTS 
Comparison  of the  Response of Normal and  Virus-Tolerant Recipients  to 
Endogenous Pyrogen.--Pooled sera from donor rabbits injected with 4 ml. NDV 
and bled 4 hours later were used as a source of endogenous pyrogen,  l This was 
given to two groups of recipients: one injected with virus the preceding day, 
and  hence  designated  "virus-tolerant"  (see  Methods);  the  other,  a  control 
group which had received no previous injections. 
Fig. 1 shows the mean fevers induced by endogenous pyrogen in both normal 
and  virus-tolerant recipients.  It  is  apparent  that  the  pyrogenic response  is 
different in these two groups. Noteworthy is the fact that in the larger dosage 
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Fzo. 1. Mean febrile responses of groups of 3 normal recipients to injection of 10 and 20 
ml. endogenous  pyrogen. Average response of 3 virus-tolerant recipients to the larger dose is 
shown for comparison.  NR, normal recipient; V-TR, virus-tolerant recipient. 
of 20 ml., endogenous pyrogen produced a  distinct second peak beginning at 
1~ hours, and reaching a maximum at 2~ to 3~ hours in the normal recipients, 
resembling the characteristic biphasic response to bacterial endotoxins or virus 
itself. With a dosage of only 10 ml. there was a prolonged monophasic response 
with the temperature still elevated 4 hours after injection. On the other hand, 
animals which had been given an injection of virus the preceding day responded 
to an injection of either dosage of endogenous pyrogen with briefer and more 
abrupt fever in which the temperature rapidly returned to normal by 2 to 2~/~ 
hours. 
Dissociation of Fever and Tolerant Response to Endogenous Pyrogen.--It was 
thought advisable to determine what role fever might have in producing the 
modified response of the virus-tolerant recipient to endogenous pyrogen. 
i Hereafter, as in the first paper of this series (1), the serum will be referred to simply as 
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One group of rabbits was inoculated with 4 ml. NDV on the day preceding the experiment. 
To block the febrile response which is normally present, 0.9 gin. antipyrine  (4.5 ml. of a solu- 
tion containing 200 rag. per ml.) was given subcutaneously 1 hour before and either 1 or 2~ 
hours after the virus. By this means, the maximal mean elevation occurring in the virus-inocu- 
lated  group was reduced to 0.35°C. A control group received the 2 injections of antipyrine 
at the same intervals. 
The following day both groups of animals were given individual  dosages of 
15  ml.  endogenous pyrogen. The results are shown in Fig.  2.  Recipients pre- 
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FIG. 2. Relation of fever to the development of tolerance to endogenous pyrogen. Average 
febrile responses of a group of 5 rabbits to 15 ml. endogenous pyrogen after suppression of 
virus fever on preceding day with antipyrine.  Mean fever induced by endogenous pyrogen in 
2 controls treated on previous day with antipyrine  only is shown for comparison. AP, anti- 
pyrine; F_.P, endogenous pyrogen. 
viously injected  with  virus  all  had  monophasic fevers.  The normal  controls, 
on the other hand, given antipyrine only, had typical but somewhat exaggerated 
biphasic fever curves. The modified response of the virus-tolerant recipient to 
endogenous pyrogen, therefore, is independent of fever associated with the pre- 
ceding  injection  of virus. 
Effect of Sera on Pyrogenicity of Endogenous Pyrogen.--The second fever peak 
produced in the normal recipient  by injection of 15  to 20 nil.  of endogenous 
pyrogen suggested two possibilities: (a) The sera contained virus to which only 
the normal recipient would respond; (b) The virus-tolerant recipient had devel- 
oped  non-specific serum inhibitors  capable of blocking the action of a  second 
pyrogenic substance  in  the  injected  sera. 406  PATHOGENESIS  0]~ lcEVER. II 
To test for the presence of virus, 15 ml. atiquots of sera containing endogenous pyrogen 
were incubated in vitro at 37°C. for 60 minutes with 5 ml. pooled immune sera (see Methods). 
Control studies had shown that the addition of this quantity of immune serum/n t~o com- 
pletely blocked the pyrogenic effect of 1 ml. NDV in 15 ml. normal serum. The combination 
of endogenous pyrogen and immune sera was then injected in individual doses of 20 ml. into 
6 normal recipients. 
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FIo. 3. Mean febrile responses of groups of normal recipients to 15 ml. endogenous pyrogen 
previously incubated with sera from normal,  immune,  or virus-tolerant animals. Average 
response of recipients to 20 ml. endogenous pyrogen after preceding inoculation  of NDV is 
shown for comparison.  Figures indicate number of rabbits used in each experiment. 
The results are shown in Fig. 3. It is apparent that the biphasic response of 
the recipients was -nmodified, indicating that  the second fever peak was not 
due to virus contained in the injected sera. 
A second experiment was designed to test for the presence of serum inhibitors in the animals 
which had been injected with virus on the preceding day. Individual doses of 15 ml. endogenous 
pyrogen were incubated with an additional 20 ml. of sera from animals which had been made 
tol~rant to virus by prior injection of NDV. The mixture was then injected into each of another 
group of 6 normal recipients. 
The addition of this serum likewise failed to modify the double peaked fever 
produced by endogenous pyrogen in the normal recipient (see Fig, 3). The fail- 
ure of the virus-tolerant recipient to respond with a  biphasic fever to the same 
dosage  of  endogenous  pyrogen,  therefore,  appeared  to  be  unrelated  to  the 
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Relation of Production of Endogenous Pyrogen to the Appearance of the Second 
Peak in Normal Recipients.--Since  there appeared to be no  evidence for the 
presence of a  second pyrogenic substance  in  the sera containing endogenous 
pyrogen, the possibility was considered that endogenous pyrogen might itself 
be responsible for both the first and second peaks of fever in the normal recipi- 
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Fro. 4. Serial transfer of endogenous pyrogen. Mean fever of donor rabbits given 30 ml. 
endogenous pyrogen. Donors were divided into 2 groups and bled at 1 hour or 3 hours as 
indicated by upright arrows. The average febrile responses of normal recipients are shown to 
15 ml. pooled sera from each interval. Sera from 2 donors bled at I hour were pooled and given 
to 4 recipients; the 3 hour sera were pooled from 3 donors and given to 3 recipients. Results 
of 2 serial transfers of pooled 50 ml. endogenous pyrogen are ~hown in shadowgraphs.  Each 
curve represents an average of 3 animals, 
ent. It was postulated that in addition to its direct pyrogenic effect, the injected 
endogenous pyrogen had  stimulated the release of the  recipient's own endog- 
enous pyrogen and thereby caused the appearance of a second febrile response. 
An injection of 30 ml. endogenous pyrogen was given to each of a group of normal animals. 
Following the injection, the animals were divided into two groups and bled at 1 and 3 hours, 
at the height of the first and second peaks of fever respectively. The sera from the 1 and 3 
hour intervals were pooled separately and then, in turn, given to two new groups of normal 
recipients. 
The results of this second serial transfer of serum are shown in Fig. 4. The 
pooled serum, obtained 1 hour after the injection of endogenous pyrogen, was 408  PATHOGENESIS  OF  FEVER.  H 
non-pyrogenic. In contrast, serum taken at 3 hours produced brief febrile re- 
sponses in the normal recipients. Similar results were obtained'in an earlier 
experiment in which smaller doses of sera were used in the two transfers. 
These findings suggest that the injection of endogenous pyrogen produces 
two separate effects, one direct and the other indirect, in the normal recipient. 
(a) There is an initial febrile response, which is presumably due to the direct 
action of endogenous pyrogen on the thermoregulatory center. Since the injected 
material is rapidly diluted in the recipient's circulation, no endogenous pyrogen 
is transferable at 1 hour during the first fever peak. (b) Following this, a second 
fever peak appears as a result of the release or activation of endogenous pyrogen 
in the normal recipient. The endogenous pyrogen produced by the recipient is 
responsible for  the  presence  of  transferable endogenous pyrogen during the 
second peak of fever at 3 hours. 
The virus-tolerant recipient, on the other hand, responds only to the initial 
direct action of endogenous pyrogen. The absence of a  second peak indicates 
that there is no further activation of endogenous pyrogen (Fig. 1). 
With larger injections of endogenous pyrogen, a serial transfer of the double 
peak may be demonstrated in normal recipients (see shadowgraph, Fig. 4). In 
this experiment, two successive transfers of 50 ml. endogenous pyrogen were 
performed after the injection of the first group of animals with NDV. 
The serial transfer of a second fever peak appears to be evidence for a self- 
activating system. A large initial injection of endogenous pyrogen stimulates 
the production of a proportionately large amount in the recipient. The transfer 
of a  sufficient dosage of the recipient's endogenous pyrogen in  turn releases 
endogenous pyrogen in a new recipient. 
Leukocyte Responses of Normal  and Tolerant Recipients  to  an Injection  of 
Endogenous Pyrogen.--The intravenous injection of bacterial pyrogen produces 
a  biphasic fever which is associated with a  prompt polymorphonuclear leuko- 
penia and the appearance of a  circulating endogenous pyrogen. It has been 
postulated that the endogenous pyrogen may be derived from leukocytes in- 
jured by the endotoxin (4-6). Since virus-induced endogenous pyrogen produces 
a biphasic febrile response, which also appears to be associated with the release 
of an endogenous pyrogen in the normal recipient, it seemed pertinent to deter- 
mine whether these findings would be preceded by a similar decrease in circulat- 
ing leukocytes. The virus-tolerant recipient, on the other hand, responds to an 
injection of endogenous pyrogen with a  brief monophasic fever which is not 
accompanied by further liberation  of endogenous pyrogen.  It  was  inferred, 
therefore, that changes in circulating leukocytes would not be expected and 
that these animals would serve as controls. 
Nine rabbits were given an injection of 4 ml. NDV on the day preceding the experiment 
and were hence designated virus-tolerant. The experimental group consisted of 9 normal 
animals. On the day of the experiment, preliminary leukocyte counts were made and  an ELISH_A ATKINS AND  WEI C,  HUANG  409 
average of 2 successive values exhibiting a variation of less than 2,000 cells was used as a 
base line. All recipients were then injected with 20 ml. endogenous pyrogen. Serial counts 
were made immediately following inoculation and thereafter  at 30 minute intervals for 4 
hours. All counts were obtained on free-flowing  blood from a succession of fresh cuts made 
distally on the marginal ear vein opposite the one used for injection. Rabbits with preliminary 
counts of less than 5,000 or more than 16,000 were eliminated. Counting was done with Tren- 
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Fzo. 5. Mean deviation of total leukocyte count of 9 normal and 9 virus-tolerant recipients 
after injection of 20 ml. endogenous pyrogen. 
net (N.B.S.) automatic pipettes  and Spencer bright-line chambers utilizing the four comer 
squares. 
The mean variations in total leukocyte counts of the two groups of animals 
after  inoculation of  endogenous pyrogen are  shown in Fig.  5.  The maximal 
changes and times of occurrence are presented in Table I. 
From the graph and the accompanying table the following facts are evident. 
(a) There was a  considerable fluctuation in the individual responses within 
each group, both with respect to degree of leukopenia or leukocytosis and the 
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(b)  The mean maximal values for both leukopenia and  leukocytosis were 
comparable in the two groups and were of small magnitude. 
(c) Only one-half of the recipients in each group showed a  rise or a fall in 
white cells that exceeded 30 per cent of the preinoculation value. With the ex- 
ception of a  single animal in the virus-tolerant group, none of the recipients 
developed a  significant leukopenia followed by leukocytosis as  characteristi- 
cally seen after the injection of bacterial endotoxins (7, 8). There doesnot appear 
to be a significant difference in the leukocytic responses of these two groups of 
TABLE  I 
Leukocytir, Responses  of Normal  and  Virus-Tolerant Recipients to Inirarenous Injection  of 
Endogenous Pyrogen 
Normal 
Mean  ...... 
Maximum fall 
Per cent  Hrs. 
40  1½ 
50  2~ 
16  1~ 
7  2~ 
28  ½ 
41  ~j 
46  3 
23  2 
24  . ~ 
30 
Maximum rise 
Per cent  Hrs. 
0 
0  u 
79  1 
156  ~i 
24  2~ 
2  2~ 
19 
16  3 
68  1 
Virus- 
tolerant 
Mean  .... 
Maximum fall 
Per cent  Hrs. 
34  I~I 
2  3 
31  2 
38  1 
21  2½ 
29 
24 
28  ¼ 
25 
Maximum rise 
Per cent 
54 
54 
14 
26 
I0 
8 
87 
139 
54 
40  26  49 
Hrs. 
3 
it 
1 
½ 
2 
3½ 
1 
3 
Preinoculation mean leukocyte counts: Normal,  10.5  -4-  t.0  X  10  ~.  Virus-tolerant,  11.2 
±  0.9 ×  I08. 
recipients to endogenous pyrogen, therefore, despite the appearance of circulat- 
ing pyrogen and a second fever peak in the normal recipient. 
DISCUSSION 
The disparity of the pyrogenic effects of viral-induced endogenous pyrogen in 
normal and virus-tolerant recipients was an unexpected finding. The biphasic 
response of the normal recipient to an injection of 15 ml. or more of endogenous 
pyrogen resembled that occurring with bacterial endotoxin. It is of interest that 
studies of an endogenous pyrogen derived from polymorphonuclear leukocytes 
showed that this material produced only a monophasic fever even when large 
dosages were given (9). Other experiments have been reported with pyrogens of 
presumably endogenous origin, obtained both from the circulations of donors 
made febri]e by the injection of typhoid vaccine (4, 5) and from the thoracic 
duct lymph of animals with pneumococcal peritonitis (10). In the amounts used, ELISHA  ATKINS  AND  WEI  C.  HUANG  411 
these substances have also produced identical  brief monophasic fevers when 
injected  into  either  normal  or  endotoxin-tolerant  recipients. ~ On  the  other 
hand, two separate series of events follow the injection of virus-induced endog- 
enous pyrogen in  the normal  recipient.  First,  there  appears  to  be  a  direct 
stimulation of the thermoregulatory center resulting in the initial fever peak. 
This phase is present in both the normal and virus-tolerant recipient. Second, 
in the normal  recipient,  there is a  release  of additional  endogenous pyrogen 
which,  in turn, produces the second fever peak. The monophasic response pro- 
duced by injected endogenous pyrogen in the animal which has received virus 
on the preceding day indicates that there is no activgtion of endogenous pyrogen 
in this recipient. 
The data, suggest,  therefore, that a sufficient dosage of endogenous pyrogen 
is self-activating in the non-tolerant recipient. The failure of endogenous pyro- 
gen obtained in other situations to produce a second peak may be due to quanti- 
tative considerations only. In support of this possibility is the observation that 
when  the dosage of serum  containing  endogenous pyrogen from  endotoxin- 
injected donors is increased to 40 ml.,  normal recipients respond with typical 
biphasic fevers (13). Similar  results have also been recently obtained with the 
transfer of large volumes of sera from animals developing fever with two experi- 
mentally induced infections (16).  Canine peritoneal exudates likewise appear 
capable of inducing a biphasic fever when injected in dogs (reference  17,  see 
shadowgraphs) suggesting,  in contrast to earlier  findings  (9), that endogenous 
pyrogen derived from granulocytes may be self-activating. 
The demonstration that viral-induced endogenous pyrogen is a self-activat- 
ing substance would seem to offer an interpretation of the biphasic fever seen 
with sufficient dosages of virus. It may also explain  the characteristic double- 
peaked fever produced by a large injection of endotoxin. Although there is good 
evidence that endotoxins can induce fever by a direct action on the thermo- 
regulatory center (18), it is not established whether they do so in the usual doses 
injected intravenously. Using a  technique of intracarotid injection, King and 
Wood have shown that circulating endotoxin appears to act by a  less direct 
mechanism than endogenous pyrogen (19). 
The  apparent  inability  of  virus-induced  endogenous  pyrogen  to  produce 
significant  changes in circulating leukocytes of either normal or tolerant recipi- 
ents provides evidence for two important points regarding  the nature and mode 
of action of this substance. 
Pyrexin, a  pyrogenic material isolated by Menkin from sterile exudates (11)  and more 
recently from serum (12), though producing a  biphasic fever, appears to be a  different sub- 
stance. Recipients tolerant to endotoxin, which react like normal recipients to the endogenous 
pyrogen described here (13),  show a  markedly decreased response to pyrexin as compared 
with controls (9). This fact, as well as the marked heat stability of pyrexin (11)  suggests a 
similarity, if not identity, with bacterial or tissue polysaccharides (14), not evident in the 
properties of endogenous pyrogen described by other investigators (15). 412  PATHOGENESIS  OF  FEVER.  H 
First, despite the considerable  fever occurring  with the dosage of endogenous 
pyrogen employed (see Fig. 1), neither group developed a consistent early leu- 
kopenia or late leukocytosis. Furthermore,  the mean maximal  values attained 
in regard to either fall or rise in circulating leukocytes are far below those usually 
seen with amounts of bacterial polysaccharides which produce a  comparable 
degree of fever (see Table I). The injection of a sufficient dosage of endotoxin 
causes a  prompt leukopenia of 50 to 70 per cent within  the first  1~  hours 
followed  usually by leukocytosis in 3  to 5 hours  (14,  20,  21).  This effect is 
markedly potentiated when endotoxin is present in serum (22). Results with 
the recently isolated tissue polysaccharides are generally similar and in the few 
cases when leukopenia was absent, a brisk leukocytosis subsequently developed 
as seen with small doses of endotoxin (14). These results would seem, therefore, 
to indicate that  endogenous pyrogen is not identical  with either bacterial or 
tissue polysaccharides? 
Second,  the leukocytic responses  of the two groups of recipients to the in- 
jected endogenous pyrogen were similar despite the occurrence  of a high second 
peak of fever in the normal group (Fig.  1). If the development of leukopenia 
is an essential  step in the release of endogenous pyrogen following inoculation 
of endotoxin,  then  the  lack  of change  in  circulating  granulocytes after  the 
injection of viral-induced endogenous pyrogen would make it appear unlikely 
that this cell is the main source of the endogenous pyrogen which is liberated 
and causes the second peak in normal recipients.  Likewise,  animals  given virus 
show no change  in the number of granulocytes during the latent period ~/or 
to the appearance of endogenous pyrogen (23, 24). In this regard, it is of interest 
that leukopenia induced by nitrogen mustard does not modify the response of 
recipients  to virus-induced  endogenous pyrogen  (1),  suggesting  further  that 
the release  of this substance is not primarily dependent upon circulating leu- 
kocytes. 
The  evidence presented indicates  that  the altered  reactivity of the virus- 
tolerant  recipient  to an injection of endogenous pyrogen cannot  be ascribed 
either to development of serum inhibitors or to fever accompanying the injec- 
tion of virus on the preceding day. In addition, since sera containing endogenous 
pyrogen do not have detectable amounts of virus (1), the difference in the re- 
sponse of the  normal  and  virus-tolerant  recipient  to endogenous pyrogen is 
not due  to  tolerance  to virus  per  se.  It  appears  that  the further  release  of 
endogenous pyrogen in the tolerant recipient may have been prevented by the 
mobilization of endogenous pyrogen on the preceding day of virus injection. 
3 Corroborative evidence for this conclusion is the fact that when rabbits are given virus, 
the appearance of endogenous pyrogen in their sera is not followed by a  fall in circulating 
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Observations have been made on the fever-inducing properties of an endog- 
enous pyrogen found in the circulation of rabbits after the intravenous inocu- 
lation of Newcastle disease virus (NDV). 
When endogenous pyrogen was given to a normal recipient, a biphasic fever 
was produced which simulated that seen with bacterial endotoxins. With the 
use of a technique of serial passive transfer, it has been shown that the "double- 
humped" response results from two separate actions of the injected pyrogen. 
The first of these appears to be a  direct stimulation of the thermoregulatory 
centers. The second involves the release of further endogenous pyrogen in the 
normal recipient to cause, in turn, the second fever peak. Since the injection of 
endogenous pyrogen did  not produce a  significant change in  the number of 
circulating leukocytes, it is inferred that this substance is different from either 
bacterial or tissue polysaccharides. 
In rabbits rendered tolerant by a previous injection of virus the second fever 
peak failed to appear and the response to endogenous pyrogen was monophasic. 
Evidence indicates  that  the  absence of a  second fever peak  in  the  tolerant 
recipient was  not due to rise in  temperature on  the preceding day of virus 
injection or to the development of either serum inhibitors or tolerance to virus 
itself. 
It is postulated that prior mobilization of endogenous pyrogen by virus may 
have modified the  ability of the tolerant recipient to liberate further amounts 
of this substance in response to an injection of endogenous pyrogen. 
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